DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Online

Drug Development Phase 2

Learn the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

概览

The Drug Development Phase 2 module is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners will learn about the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

Estimated time to complete module: 1.25 hours

This eLearning module can be purchased individually or as part of the Drug Development and Lifecycle Management eLearning Program.

精选主题

  • Objectives and key players
  • Regulatory activities
  • Clinical R&D and biostatistics activities
  • Case study part 1
  • End of phase 2
  • Case study part 2
  • Review

谁应该参加?

This module is designed for individuals who are new to, or changing roles in, the pharmaceutical and biotechnology industries. The module will also benefit professionals who work in the areas of:

  • Clinical Research
  • Project Management
  • Administrative Support
  • Quality Assurance
  • Regulatory Affairs
  • Manufacturing
  • Medical writing
  • Business Support

学习目标

  • At the conclusion of this course, participants should be able to:

    • List the key objectives and activities of phase 2
    • Recognize the regulatory activities and decisions that occur during phase 2
    • Identify risk-return decisions involved in phase 2

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。